CureBay Secures $7.4 Million in Series A1 Funding to Advance Healthtech Innovations

CureBay’s Series A1 Funding Propels Healthtech Revolution, Fuels Vision for Intelligent Healthcare Ecosystem

In a significant stride towards revolutionizing the healthcare landscape, CureBay, a pioneering Healthtech startup, recently announced a successful fundraising round. The company secured a notable sum of INR 62 Crores (approximately $7.4 million) in its Series A1 funding, with Elevar Equity leading the investment charge.

Founded in 2021 by the visionary trio of Priyadarshi Mohapatra, Shobhan Mahapatra, and Sanjay Swain, CureBay has rapidly carved a niche for itself in the digital health sector. The startup’s core offerings include teleconsultations with healthcare professionals and an extensive network of microsatellite healthcare centers.

What sets CureBay apart is not just its commitment to providing accessible healthcare but also its strategic approach to leveraging technology. The infusion of funds from this latest round will be channeled into the development of an intelligent and robust health data platform. This platform is poised to revolutionize the way healthcare data is managed, facilitating seamless interactions between healthcare providers, patients, and other stakeholders in the ecosystem.


Interestingly, the funding round saw active participation from CureBay’s own founders and key members of its leadership team, showcasing their unwavering belief in the company’s mission and potential.

Priyadarshi Mohapatra, co-founder of CureBay, expressed enthusiasm about the future prospects, stating, “This funding round is a testament to the value we have created in the healthtech space. We are excited about the possibilities that lie ahead and are committed to utilizing these funds strategically.”

The primary objectives for utilizing the fresh capital include expanding the team with the recruitment of over 200 professionals. This strategic hiring will span various roles, including data scientists, diagnostics experts, and pharmacy professionals. The infusion of diverse talents aims to fortify CureBay’s capabilities and drive innovation across its spectrum of healthcare solutions.

The funding secured by CureBay not only underscores the confidence that investors, including Elevar Equity, have in the startup but also highlights the growing importance of Healthtech solutions in the contemporary healthcare landscape. As the company continues its trajectory towards growth and innovation, it undoubtedly remains one to watch in the evolving healthtech sector.

Leave a comment